What is HYPD stock price today?

HYPD (Hyperion Defi Inc) stock is trading at $4.46 as of the latest market data. Stock prices update in real-time during market hours (9:30 AM - 4:00 PM ET).

Is HYPD stock going up or down today?

HYPD stock price movements are influenced by market conditions, news, earnings reports, and investor sentiment. Check our live dashboard for real-time price changes and technical indicators.

Should I buy HYPD stock now?

The decision to buy HYPD depends on your investment strategy, risk tolerance, and financial goals. Our AI analysis evaluates fundamentals, valuation metrics, growth prospects, and market conditions to help inform your decision.

Is HYPD a buy, hold, or sell right now?

Our AI-powered analysis provides buy/hold/sell recommendations for HYPD based on multiple factors including valuation, growth metrics, technical indicators, and analyst consensus. Visit our dashboard for the latest recommendation.

Is HYPD stock overvalued or undervalued?

Use our DCF valuation calculator to determine if HYPD is overvalued or undervalued based on fundamental analysis and future cash flow projections.

What is HYPD's P/E ratio?

P/E ratio data for HYPD will be available after the company reports earnings. Visit our dashboard for the latest financial metrics.

What is HYPD's market cap?

HYPD (Hyperion Defi Inc) has a market capitalization of $0.04 billion, making it a small-cap stock.

What is HYPD's price to book ratio?

HYPD trades at a price-to-book (P/B) ratio of 1.08, which compares the stock price to the company's book value per share. A P/B below 1.0 may indicate undervaluation, while above 3.0 may suggest premium pricing.

Does HYPD pay dividends?

HYPD does not currently pay dividends. Many growth companies reinvest profits into the business rather than paying dividends.

What is HYPD's dividend yield?

HYPD does not currently pay dividends or dividend data is not available. Check our dashboard for the latest information.

Is HYPD stock a good long-term investment?

HYPD's long-term investment potential depends on sustainable competitive advantages, revenue growth, profitability, management quality, and industry dynamics. Our AI analysis evaluates these factors to assess long-term prospects.

What is HYPD's revenue growth rate?

HYPD has shown revenue growth of 16.7% over recent periods. Consistent revenue growth is a key indicator of business health and competitive positioning.

Profitability metrics for HYPD are available on our dashboard with complete income statement analysis.

What are the risks of investing in HYPD?

Key risks for HYPD include market volatility, competitive pressures, regulatory changes, economic conditions, execution risks, and company-specific factors. Our AI analysis identifies material risks and their potential impact on valuation.

How does HYPD compare to its competitors?

Compare HYPD to industry peers on our dashboard using metrics like P/E ratio, revenue growth, profit margins, market share, and valuation multiples. Competitive analysis helps contextualize HYPD's performance and positioning.

What is HYPD's stock price target for 2026?

Our AI model provides price targets for HYPD based on fundamental analysis: Bull case $5.80 (+30%), Base case $5.13 (+15%), Bear case $4.01 (-10%). Visit our prediction page for detailed forecasts.

What do analysts say about HYPD?

Wall Street analysts provide ratings (buy/hold/sell) and price targets for HYPD. Our dashboard aggregates analyst consensus, target prices, and recent upgrades/downgrades to help you understand professional sentiment.

When is HYPD's next earnings report?

HYPD reports earnings quarterly. Check our dashboard for the upcoming earnings date, analyst estimates for revenue and EPS, and historical earnings performance. Earnings reports often drive significant stock price movements.

HYPD - Hyperion Defi Inc

NYSE * Health Care * Pharmaceuticals

$4.46

+$0.55 (+14.07%)

About Hyperion Defi Inc

Hyperion DeFi, Inc., an ophthalmic technology company, engages in development and commercialization of ophthalmic solutions in the United States. The company offers Optejet, a topical ophthalmic medication dispensing platform services. It has a license agreement with Bausch Health Ireland Limited to develop and commercialize MicroPine in the United States and Canada; a license agreement with Arctic Vision (Hong Kong) Limited to develop and commercialize MicroPine, MicroLine, and Mydcombi in China and South Korea; Senju Pharmaceutical Co., Ltd. to develop and commercialize MicroPine, MicroLine, and Mydcombi; and agreement with Formosa Pharmaceuticals. Inc. for Co-Development of Clobetasol Propionate Ophthalmic Suspension (0.05%) for the Treatment of Acute Dry Eye Disease in the U.S. The company was formerly known as Eyenovia, Inc. and changed its name to Hyperion DeFi, Inc. in July 2025. Hyperion DeFi, Inc. was founded in 2014 and is based in New York, New York.

HYPD Key Statistics

Market Cap

$44.54M

P/B Ratio

1.08

EPS

$-9.40

Revenue Growth

+16.7%

Employees

How HYPD Compares to Peers

HYPD has the fastest revenue growth among competitors

HYPD is the smallest among peers, which may offer higher growth potential

P/E Rank

N/A

of 1

Margin Rank

N/A

of 1

Growth Rank

of 2

Size Rank

of 2

Company	Market Cap	P/E	Growth	Margin	Compare
HYPD(This stock)	$44.54M	N/A	17%	0.0%	-
AMZNAmazon Com	$2.69T	34.8	0%	0.1%	vs AMZN

Hyperion Defi Inc Company Information

Headquarters: New York; U.S.A
Website: hyperiondefi.com
Sector: Health Care
Industry: Pharmaceuticals

HYPD - Hyperion Defi Inc

About Hyperion Defi Inc

HYPD Key Statistics

How HYPD Compares to Peers

Hyperion Defi Inc Company Information

HYPD Lician Score

HYPD Financial Snowflake

Upcoming Events for HYPD